...
tyra-img

Tyra Biosciences Inc, Common Stock

TYRA

NSQ

$14.465

-$0.76

(-4.99%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$770.18M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
72.02K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.08
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$11.24 L
$29.6 H
$14.465

About Tyra Biosciences Inc, Common Stock

Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is TYRA-300, which is in Phase 1/2 clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, thanatophoric dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in Phase 1 clinical trial for bile duct and solid tumors; and TYRA-430 for the treatment of hepatocellular carcinoma. The company was incorporated in 2018 and is headquartered in Carlsbad, California. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameTYRASectorS&P500
1-Week Return-6.22%-3.39%0.2%
1-Month Return-1.62%-1.92%2.72%
3-Month Return-31.93%-10.54%7.31%
6-Month Return-14.25%-4.47%10.44%
1-Year Return17.17%4.06%27.53%
3-Year Return21.66%0.94%30.88%
5-Year Return-41.46%36.67%89.21%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue8.00K47.00K140.00K296.00K353.00K[{"date":"2019-12-31","value":2.27,"profit":true},{"date":"2020-12-31","value":13.31,"profit":true},{"date":"2021-12-31","value":39.66,"profit":true},{"date":"2022-12-31","value":83.85,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit(8.00K)(47.00K)(140.00K)(296.00K)(353.00K)[{"date":"2019-12-31","value":-800000,"profit":false},{"date":"2020-12-31","value":-4700000,"profit":false},{"date":"2021-12-31","value":-14000000,"profit":false},{"date":"2022-12-31","value":-29600000,"profit":false},{"date":"2023-12-31","value":-35300000,"profit":false}]
Gross Margin(Infinity%)(Infinity%)(Infinity%)(Infinity%)(Infinity%)[{"date":"2019-12-31","value":null,"profit":false},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Operating Expenses3.12M9.30M26.29M58.93M79.94M[{"date":"2019-12-31","value":3.91,"profit":true},{"date":"2020-12-31","value":11.63,"profit":true},{"date":"2021-12-31","value":32.88,"profit":true},{"date":"2022-12-31","value":73.71,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(3.12M)(9.30M)(26.29M)(58.93M)(79.94M)[{"date":"2019-12-31","value":-312200000,"profit":false},{"date":"2020-12-31","value":-929700000,"profit":false},{"date":"2021-12-31","value":-2628800000,"profit":false},{"date":"2022-12-31","value":-5892700000,"profit":false},{"date":"2023-12-31","value":-7994500000,"profit":false}]
Total Non-Operating Income/Expense(944.00K)(40.00K)7.00K7.25M21.66M[{"date":"2019-12-31","value":-4.36,"profit":false},{"date":"2020-12-31","value":-0.18,"profit":false},{"date":"2021-12-31","value":0.03,"profit":true},{"date":"2022-12-31","value":33.49,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(4.07M)(9.34M)(26.29M)(55.33M)(69.13M)[{"date":"2019-12-31","value":-406500000,"profit":false},{"date":"2020-12-31","value":-933600000,"profit":false},{"date":"2021-12-31","value":-2629400000,"profit":false},{"date":"2022-12-31","value":-5532500000,"profit":false},{"date":"2023-12-31","value":-6913400000,"profit":false}]
Income Taxes(7.00K)(22.00K)(153.00K)(3.60M)-[{"date":"2019-12-31","value":-700000,"profit":false},{"date":"2020-12-31","value":-2200000,"profit":false},{"date":"2021-12-31","value":-15300000,"profit":false},{"date":"2022-12-31","value":-360200000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes(4.06M)(9.31M)(26.14M)(51.72M)-[{"date":"2019-12-31","value":-405800000,"profit":false},{"date":"2020-12-31","value":-931400000,"profit":false},{"date":"2021-12-31","value":-2614100000,"profit":false},{"date":"2022-12-31","value":-5172300000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations(4.07M)(9.34M)(26.29M)(55.33M)(69.13M)[{"date":"2019-12-31","value":-406500000,"profit":false},{"date":"2020-12-31","value":-933600000,"profit":false},{"date":"2021-12-31","value":-2629400000,"profit":false},{"date":"2022-12-31","value":-5532500000,"profit":false},{"date":"2023-12-31","value":-6913400000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(4.06M)(9.31M)(26.14M)(51.72M)(69.13M)[{"date":"2019-12-31","value":-405800000,"profit":false},{"date":"2020-12-31","value":-931400000,"profit":false},{"date":"2021-12-31","value":-2614100000,"profit":false},{"date":"2022-12-31","value":-5172300000,"profit":false},{"date":"2023-12-31","value":-6913400000,"profit":false}]
EPS (Diluted)(1.07)(6.97)(1.24)(1.33)(1.61)[{"date":"2019-12-31","value":-106.7,"profit":false},{"date":"2020-12-31","value":-697.2,"profit":false},{"date":"2021-12-31","value":-124,"profit":false},{"date":"2022-12-31","value":-133,"profit":false},{"date":"2023-12-31","value":-161,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

TYRA
Cash Ratio 29.11
Current Ratio 29.55

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

TYRA
ROA (LTM) -20.21%
ROE (LTM) -28.66%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

TYRA
Debt Ratio Lower is generally better. Negative is bad. 0.05
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.95

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

TYRA
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 2.13
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Tyra Biosciences Inc share price today?

Tyra Biosciences Inc (TYRA) share price today is $14.465

Can Indians buy Tyra Biosciences Inc shares?

Yes, Indians can buy shares of Tyra Biosciences Inc (TYRA) on Vested. To buy Tyra Biosciences Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TYRA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Tyra Biosciences Inc be purchased?

Yes, you can purchase fractional shares of Tyra Biosciences Inc (TYRA) via the Vested app. You can start investing in Tyra Biosciences Inc (TYRA) with a minimum investment of $1.

How to invest in Tyra Biosciences Inc shares from India?

You can invest in shares of Tyra Biosciences Inc (TYRA) via Vested in three simple steps:

  • Click on Sign Up or Invest in TYRA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Tyra Biosciences Inc shares
What is Tyra Biosciences Inc 52-week high and low stock price?

The 52-week high price of Tyra Biosciences Inc (TYRA) is $29.6. The 52-week low price of Tyra Biosciences Inc (TYRA) is $11.24.

What is Tyra Biosciences Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Tyra Biosciences Inc (TYRA) is

What is Tyra Biosciences Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Tyra Biosciences Inc (TYRA) is 2.13

What is Tyra Biosciences Inc dividend yield?

The dividend yield of Tyra Biosciences Inc (TYRA) is 0.00%

What is the Market Cap of Tyra Biosciences Inc?

The market capitalization of Tyra Biosciences Inc (TYRA) is $770.18M

What is Tyra Biosciences Inc’s stock symbol?

The stock symbol (or ticker) of Tyra Biosciences Inc is TYRA

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top